| Company/Division name | GenCure |
| Parent company | BioBridge Global |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2022 |
| City reshored to: | San Antonio |
| State(s) reshored to: | TX |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | cell and gene therapy solutions |
| What domestic positive factors made reshoring more attractive? | Automation/technology, Customization/Flexibility, Eco-system synergies, Manufacturing/engineering joint innovation (R&D) |
